Neuroprotection by a Central Nervous System–Type Prostacyclin Receptor Ligand Demonstrated in Monkeys Subjected to Middle Cerebral Artery Occlusion and Reperfusion
Authors:
- Hiroyuki TakamatsuHTHiroyuki Takamatsu
- Takeharu KakiuchiTKTakeharu Kakiuchi
- Hiroyuki OhbaHOHiroyuki Ohba
- Yosky KataokaYKYosky Kataoka
- Chihiro YokoyamaCYChihiro Yokoyama
- Hirotaka OnoeHOHirotaka Onoe
- Yumiko WatanabeYWYumiko Watanabe
- Takamitsu HosoyaTHTakamitsu Hosoya
- Masaaki SuzukiMSMasaaki Suzuki
- Ryoji NoyoriRNRyoji Noyori
- Hideo TsukadaHTHideo Tsukada
- 1 November 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 37 (11) , 2830-2836
Abstract
Background and Purpose— Recently, we found that a novel subtype of prostacyclin (PGI 2 ) receptor clearly distinct from the peripheral subtype in terms of ligand specificity is expressed in the central nervous system (CNS). (15R)-16- m -tolyl-17,18,19,20-tetranorisocarbacyclin (15R-TIC) was synthesized and demonstrated to be a specific ligand for this CNS-type PGI 2 receptor. Previously, we demonstrated 15R-TIC to be neuroprotective in vivo during transient forebrain ischemia in gerbils and permanent middle cerebral artery occlusion (MCAO) in rats. Furthermore, this compound was shown to exert an anti-apoptotic effect on primary cultured hippocampal neurons, indicating its neuroprotective effect against ischemic insults occurs via direct action on CNS-type PGI 2 receptor. Methods— Local cerebral hemodynamics and oxygen metabolism were measured simultaneously by using positron emission tomography with the 15 O steady-state method, before and up to 18 hours after 3-hour transient MCAO reperfusion in cynomolgus monkeys. Methyl ester of 15R-TIC (50 μg/kg, n=4) or its vehicle (10% Intralipos, n=4) was injected intravenously within 5 minutes after onset of MCAO and continuously infused for 5 hours (50 μg/kg per hour). Results— Neuropathology showed that 15R-TIC significantly reduced cortical damage after 3-hour MCAO. Positron emission tomography results showed 15R-TIC significantly reduced the volume of “infarct” region of interest and attenuated the decrease in cerebral metabolic rate of oxygen and oxygen extraction fraction, and these protective effects were not attributable to improvement of cerebral circulation. Conclusions— These results suggest that 15R-TIC has a potent neuroprotective effect against focal cerebral ischemia in a monkey MCAO via its direct action on CNS-type PGI 2 receptors.Keywords
This publication has 16 references indexed in Scilit:
- Specific ligand for a central type prostacyclin receptor attenuates neuronal damage in a rat model of focal cerebral ischemiaBrain Research, 2002
- A metabolic threshold of irreversible ischemia demonstrated by PET in a middle cerebral artery occlusion-reperfusion primate model*Acta Neurologica Scandinavica, 2000
- Protective Effect of Prostaglandin I2 Analogs on Ischemic Delayed Neuronal Damage in GerbilsBiochemical and Biophysical Research Communications, 1999
- A Novel Subtype of the Prostacyclin Receptor Expressed in the Central Nervous SystemJournal of Biological Chemistry, 1996
- (15 R)‐16‐m‐Tolyl‐17,18,19,20‐tetranorisocarbacyclin: A Stable Ligand with High Binding Affinity and Selectivity for a Prostacyclin Receptor in the Central Nervous SystemAngewandte Chemie International Edition, 1996
- PET Study of Changes in Local Brain Hemodynamics and Oxygen Metabolism after Unilateral Middle Cerebral Artery Occlusion in BaboonsJournal of Cerebral Blood Flow & Metabolism, 1993
- Influence of prostacyclin on early morphological changes in the rabbit brain after complete 20-min ischemiaJournal of the Neurological Sciences, 1985
- SERIAL OBSERVATIONS ON THE PATHOPHYSIOLOGY OF ACUTE STROKEBrain, 1983
- EIGHTH GADDUM MEMORIAL LECTURE UNIVERSITY OF LONDON INSTITUTE OF EDUCATION DECEMBER 1980: BIOLOGICAL IMPORTANCE OF PROSTACYCLINBritish Journal of Pharmacology, 1982
- Cerebral artery spasmJournal of Neurosurgery, 1978